NCT05913336View on ClinicalTrials.gov

A Study of Remimazolam Tosilate for Prolonged Sedation in the ICU

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 27, 2023

Primary Completion Date

March 5, 2025

Study Completion Date

March 5, 2025

Conditions
Sedation in the ICU
Interventions
DRUG

Remimazolam Tosilate

Loading dose: 0.08mg/kg , Maintenance dose: IV remimazolam tosilate, dose range 0-2.0mg/kg/h, increment or decrement of 0.1-0.2mg/kg/h

Trial Locations (1)

550001

The Affiliated Hospital of Guizhou Medical University, Guiyang

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY